Search
Translation
  • Home
  • Company
    • In the Media
    • Board of Directors
    • Management Team
    • Medical Advisory Board
  • Technology
  • Products
    • Testimonials
    • ActiPatch
    • Smart Insole
    • Allay
    • RecoveryRx
    • HealFast
  • Clinical Evidence
    • Pain Overview
    • Published Clinical Literature
    • Cell Studies
    • Musculoskeletal Pain
    • Menstrual Pain
    • Postoperative Pain & Edema
    • Chronic Wounds
  • Distributors
    • Distribution Opportunities
    • Market Clearances
  • Investors
    • FDA Status
    • Investors Financials
    • Letter from the President
    • Press Releases
    • Investor Updates
  • Contact

Investors Financials

 

2013 Financials

  • BIEL Financial Statements For Quarter Ending March 31, 2013

 

2012 Financials

  • BIEL 2012 OTC Annual Filing
  • BIEL Financial Statements For Quarter Ending September 30, 2012
  • BIEL Financial Statements For Quarter Ending June 30, 2012
  • BIEL Financial Statements For Quarter Ending March 31 2012

 

2011 Financials

  • BIEL 2011 OTC Annual Filing
  • BIEL 2011 Financial Statements for Period Ending December 31, 2011
  • BIEL Financial Statements For Quarter Ending September 30, 2011
  • BIEL Financial Statements For Quarter Ending June 30, 2011
  • BIEL Financial Statements For Quarter Ending March 31 2011

 

2010 Financials

  • BIEL 2010 Financial Statements for Period Ending 12-31-10
  • Form 10-Q Quarterly Report for the Period Ending 09-30-10
  • Form 10-Q Quarterly Report for the Period Ending 06-30-10
  • Form 10-Q Quarterly Report for the Period Ended 03-31-10

 

2009 Financials

  • Form 10-K Annual Report for the Fiscal Year Ended 12-31-09
  • Financial Statement for Period Ending September 30, 2009
  • Financial Statement for Period Ending June 30, 2009
  • Financial Statement for Period Ending March 31, 2009

 

2008 Financials

  • Audited Financial Statements Period from April 10, 2000 (Inception) to December 31, 2008
  • FDA Status
  • Investors Financials
  • Letter from the President
  • Press Releases
  • Investor Updates

Upcoming Events

  • FIME Tradeshow 2013

    DATE: August 7-9, 2013 LOCATION: Miami Beach, FL USA BOOTH #: 2653 FIME is the largest International Medical Trade Fair…

Recent Posts

  • BioElectronics Investor Update – Thursday, June 6, 2013

    http://bielcorp.com/investors/investor-updates/


    Investor Updates
    www.bielcorp.com
    In addition to our six published medical journal studies and one pending publication, BioElectronics has been working hard to expand on its clinical research program. As previously stated, BioElectronics has a number of randomized controlled trials, case studies and cell biology studies ongoing:

Contact Us!

We are the makers of

We are the developers of ActiPatch®, RecoveryRx™, HealFast® and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices.

Call Us Today!

Contact Us
Have questions?
Call us toll free M-F, 8am - 5pm EST at
1-866-757-2284
Or email: info@bielcorp.com

Award Winning Technology

In 2009, BioElectronics was a proud runner-up for the prestigious Wall Street Journal Technology Innovation Awards. In 2013, our ActiPatch® Product was cited for “Most Innovative New OTC Product” runner up award from the OTC Bulletin, a leading UK-based Healthcare Marketing Publication.

Testimonials

Loading Quotes...

Copyright © BioElectronics Corporation | 4539 Metropolitan Ct. Frederick, MD 21704 | 1-866-757-2284